felbinac trometamol
/ Shijiazhuang Yiling Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
May 22, 2023
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
(clinicaltrials.gov)
- P3 | N=306 | Completed | Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Enrolling by invitation ➔ Completed
Trial completion • Pain
May 22, 2023
A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China
(clinicaltrials.gov)
- P3 | N=264 | Completed | Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Enrolling by invitation ➔ Completed
Trial completion • Gynecology • Pain
March 28, 2022
A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China
(clinicaltrials.gov)
- P3 | N=264 | Enrolling by invitation | Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
New P3 trial • Gynecology • Pain
January 20, 2022
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
(clinicaltrials.gov)
- P3; N=336; Enrolling by invitation; Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd; Trial completion date: Jun 2021 ➔ Apr 2022; Trial primary completion date: May 2021 ➔ Dec 2021
Clinical • Trial completion date • Trial primary completion date • Pain
August 25, 2020
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
(clinicaltrials.gov)
- P3; N=336; Enrolling by invitation; Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
New P3 trial • Pain
1 to 5
Of
5
Go to page
1